SCHEMBL4139952

SCHEMBL4139952

CCN(C(=O)c1ccccc1)C1CCCCC1

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.62
HSD11B1 P28845 1/20 0.61
AGER Q15109 3/20 0.58
MTNR1A P48039 1/20 0.58
SLC6A2 P23975 1/20 0.52
SLC6A4 P31645 1/20 0.52
ALDH1A1 P00352 1/20 0.52
CCR5 P51681 1/20 0.52
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
LMNA P02545 1/20 0.50
MAPT P10636 1/20 0.50
HTT P42858 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
ADORA2A P29274 1/20 0.50
TSHR P16473 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13434090 0.92 L3MBTL1 (0.51) L3MBTL1HSD11B1AGERMTNR1AALDH1A1
SCHEMBL10722280 0.92 HSD11B1 (0.70) L3MBTL1HSD11B1AGERMTNR1AMEN1
SCHEMBL10720234 0.89 HSD11B1 (0.56) L3MBTL1HSD11B1AGERMTNR1AALDH1A1
SCHEMBL13911269 0.88 AGER (0.56) L3MBTL1HSD11B1AGERMTNR1ASLC6A4
SCHEMBL1353088 0.86 LMNA (0.65) L3MBTL1HSD11B1AGERMTNR1AMEN1
SCHEMBL10720319 0.85 L3MBTL1 (0.60) L3MBTL1HSD11B1SLC6A2SLC6A4ALDH1A1
SCHEMBL9001746 0.85 HSD11B1 (0.54) L3MBTL1HSD11B1AGERMTNR1ASLC6A4
SCHEMBL5599731 0.84 HSD11B1 (0.46) L3MBTL1HSD11B1AGERMTNR1AALDH1A1
SCHEMBL4634860 0.84 SLC6A4 (0.57) L3MBTL1HSD11B1SLC6A2SLC6A4
SCHEMBL96038 0.84 HSD11B1 (0.62) L3MBTL1HSD11B1AGERMTNR1AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101962384-A Chromene compounds, a process for their preparation and pharmaceutical compositions containing them SERVIER LAB 2011-02-02 CN claimed
CN-102365280-B adenosine receptor ligands and uses thereof DOMAIN THERAPEUTICS (FR) 2014-10-29 CN disclosed
CN-101962384-B Chromene compounds, a process for their preparation and pharmaceutical compositions containing them SERVIER LAB 2013-04-10 CN disclosed
CN-101962384-A Chromene compounds, a process for their preparation and pharmaceutical compositions containing them SERVIER LAB 2011-02-02 CN disclosed
EP-2021004-A2 SUBSTITUTED AZASPIRO DERIVATIVES NEUROGEN CORPORATION (US) 2009-02-11 EP disclosed
WO-2007133561-A2 SUBSTITUTED AZASPIRO DERIVATIVES NEUROGEN CORPORATION (US) 2007-11-22 WO disclosed
EP-1740584-A1 FUSED QUINOLINE DERIVATIVE AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2007-01-10 EP disclosed
WO-2005105802-A1 FUSED QUINOLINE DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-11-10 WO disclosed